Enliven Therapeutics Inc (ELVN) USD0.001

Sell:$53.09Buy:$53.20Price increased$2.34 (4.60%)

NASDAQ:Price decreased1.40%
Market closed |
Prices delayed by at least 15 minutes
Sell:$53.09
Buy:$53.20
Change:Price increased$2.34 (4.60%)
Market closed |
Prices delayed by at least 15 minutes
Sell:$53.09
Buy:$53.20
Change:Price increased$2.34 (4.60%)
Market closed |
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
6 July 2026
Lori Anne KunkelDirector
Sell
Regular sell transaction (market)
4,111$49.98$205,481.7647,773
6 July 2026
Lori Anne KunkelDirector
Sell
Regular sell transaction (market)
5,889$50.84$299,421.4941,884
22 June 2026
ORBIMED ADVISORS LLCPrivate Equity
Sell
Regular sell transaction (market)
787,024$45.38$35,715,149.126,601,878
22 June 2026
ORBIMED ADVISORS LLCPrivate Equity
Sell
Regular sell transaction (market)
46,776$45.00$2,104,920.006,555,102
22 June 2026
ORBIMED ADVISORS LLCPrivate Equity
Sell
Regular sell transaction (market)
24,846$45.38$1,127,511.48220,882
22 June 2026
ORBIMED ADVISORS LLCPrivate Equity
Sell
Regular sell transaction (market)
1,477$45.00$66,465.00219,405
17 June 2026
Benjamin (Ben) HohlCFO
Sell
Option/Award related
1,379$42.79$59,000.5255,639
17 June 2026
Benjamin (Ben) HohlCFO
Sell
Option/Award related
3,401$43.86$149,179.4252,238
17 June 2026
Benjamin (Ben) HohlCFO
Sell
Option/Award related
1,238$44.75$55,397.4151,000
17 June 2026
Helen Louise CollinsOther Level A
Sell
Option/Award related
1,268$42.83$54,304.6428,732

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
22 June 2026
ORBIMED ADVISORS LLCPrivate Equity
Sell
Regular sell transaction (market)
787,024$45.38$35,715,149.126,601,878
15 June 2026
ORBIMED ADVISORS LLCPrivate Equity
Sell
Regular sell transaction (market)
272,322$45.02$12,259,936.447,388,902
22 June 2026
ORBIMED ADVISORS LLCPrivate Equity
Sell
Regular sell transaction (market)
46,776$45.00$2,104,920.006,555,102
9 January 2026
Joseph P (Joe) LyssikatosPresident
Sell
Regular sell transaction (market)
50,000$29.13$1,456,715.00765,188
25 March 2026
Helen Louise CollinsOther Level A
Sell
Option/Award related
40,000$35.10$1,404,024.0025,000

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.